Ki Hong Kim
Papers
2
Total Citations
39
H-Index
2
About
Dr. Ki Hong Kim is a prominent urologic oncologist whose research focuses on advancing minimally invasive surgical treatments for kidney and prostate cancers. His work centers on optimizing outcomes for patients with small renal masses and localized prostate cancer through comparative effectiveness studies. Dr. Kim’s most cited paper, “Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses” (2018, 24 citations), provides critical comparative data on two leading nephron-sparing approaches, helping to guide clinical decision-making for early-stage kidney tumors. In another influential study, “Single Positive Lymph Node Prostate Cancer Can Be Treated Surgically without Recurrence” (2016, 15 citations), he demonstrated that select patients with limited nodal involvement can achieve favorable outcomes through surgery alone, challenging the necessity of immediate adjuvant therapy. These contributions have practical implications for reducing overtreatment and preserving organ function. Dr. Kim’s research is characterized by its direct clinical relevance, leveraging institutional databases to generate evidence that shapes surgical practice. His work continues to influence the evolving landscape of robotic and focal therapies in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2